Jazz Pharmaceuticals' low P/S ratio is due to slower revenue...
Jazz Pharmaceuticals' low P/S ratio is due to slower revenue growth compared to industry trend, leading to discomfort amongst shareholders and stock devaluation. Persisting sluggish growth may decrease P/S ratio even further unless fortunes change.
Jazz Pharmaceuticals Plc's (NASDAQ:JAZZ) Shares Lagging The Industry But So Is The Business
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment